0709 203000 - Nairobi 0709 983000 - Kilifi
0709 203000 - NRB 0709 983000 - Kilifi
0709 203000 - NRB | 0709 983000 - Kilifi

Back Home

Mainga Hamaluba/Front Immunol


3 results

B and T cell responses to pre-erythrocytic R21/Matrix-M and blood-stage RH5.1/Matrix-M malaria vaccines in endemic settings.Bundi CK Mu├▒oz O Kibwana E Bellamy D Stockdale L Barrett JR McHugh K Mtaka I Kalinga W Kimani D Nyamako L Keter K Ogwang R Hill AVS Bejon P Hamaluba M Silk SE Minassian AM Draper SJ Olotu AI Kapulu MC Ewer KJ Nielsen CM
Front Immunol, (2026). 17:1743327

R21/Matrix-M malaria vaccine drives diverse immune responses in pre-exposed adults: insights from a phase IIb controlled human malaria infection trial.Kibwana E Bundi C Kimani D Nyamako L Keter K Mutiso A Ogwang R Bellamy D Rapi K Bajer A Provstgaard-Morys S Stockdale L Munoz O Datoo MS Lawrie A Ramos-Lopez F Roberts R Hamaluba M Hill AVS Bejon P Ewer KJ Kapulu M
Front Immunol, (2025). 16:1620365

Vaccine-induced responses to R21/Matrix-M - an analysis of samples from a phase 1b age de-escalation, dose-escalation trial.Bundi C Bellamy D Kibwana E Nyamako L Ogwang R Keter K Kimani D Salman AM Provstgaard-Morys S Stockdale L Hill AVS Bejon P Olotu A Hamaluba M Ewer KJ Kapulu MC
Front Immunol, (2025). 16:1620366